Company
Headquarters: Taipei, Taiwan
TW$3.30 Billion
TWD as of July 1, 2024
US$101.4 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $121.36 B |
| Regeneron Pharmaceuticals, Inc. | $115.11 B |
| CSL Limited | $95.75 B |
| Marinomed Biotech AG | $75.67 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company's products include osteoarthritis treatment products, osteoporosis treatment preparations, iron preparations, antivirals preparations, urinary system treatment products, expectorants/mucolytic agents, antineoplastics agents, anti-hypertensive preparations, and anti-diabetic preparations, anti-adhesion systems, pellefeel wound care systems, Philips non-invasive ventilators, and others, as well as medical devices and functional foods. It is also developing TCM-800B for the treatment of hepatitis B; PTX-9908 for the treatment of liver cancer; and PTD-9908 for the anti-PD-1 treatment. The company sells its products in Taiwan, the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines, China, and internationally. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
TCM Biotech International Corp has the following listings and related stock indices.
Stock: TWSE: 4169 wb_incandescent